Latest Articles

Publication Date
miR-21 regulates autophagy and apoptosis of ectopic endometrial stromal cells of adenomyosis via PI3K/ AKT/ mTOR pathway - Nature.com

miR-21 regulates autophagy and apoptosis of ectopic endometrial stromal cells of adenomyosis via PI3K/ AKT/ mTOR pathway Nature.com

Published: March 4, 2025, 5:55 p.m.
Establishment of a Novel In Vitro and In Vivo Model to Understand Molecular Carcinogenesis of Endometriosis-Related Ovarian Neoplasms.

The molecular mechanisms through which endometriosis-related ovarian neoplasms (ERONs) develop from benign endometrioma remain unclear. It is especially a long-standing mystery why ovarian endometrioma has the potential to develop into …

Published: Feb. 25, 2025, midnight
Single-cell transcriptomic atlas of different endometriosis indicating that an interaction between endometriosis-associated mesothelial cells (EAMCs) and ectopic stromal cells may influence progesterone resistance.

Endometriosis is a hormone-dependent disease, which can usually be divided into peritoneal endometriosis (PEM), deep-infiltrating endometriosis (DIE) and ovarian endometriosis (OEM). Although the three pathologic types are essentially the same …

Published: Feb. 20, 2025, 12:34 a.m.
ERS regulates endometrial epithelial cell autophagy through XBP1s -mediated activation of the PI3K/AKT pathway - Nature.com

ERS regulates endometrial epithelial cell autophagy through XBP1s -mediated activation of the PI3K/AKT pathway Nature.com

Published: Feb. 18, 2025, 5:33 p.m.
ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer - Pharmacy Times

ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer Pharmacy Times

Published: Feb. 10, 2025, 2:34 p.m.
FDA Grants Breakthrough Status to Endometrial Cancer Assay - www.oncnursingnews.com/

FDA Grants Breakthrough Status to Endometrial Cancer Assay www.oncnursingnews.com/

Published: Feb. 9, 2025, 3:01 p.m.
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay - Medical Device Network

FDA grants breakthrough designation for Acrivon’s endometrial cancer assay Medical Device Network

Published: Feb. 6, 2025, 10 a.m.
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay - Yahoo! Voices

FDA grants breakthrough designation for Acrivon’s endometrial cancer assay Yahoo! Voices

Published: Feb. 6, 2025, 9:54 a.m.
FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer - OncLive

FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer OncLive

Published: Feb. 5, 2025, 5:17 p.m.
Acrivon Therapeutics Announces FDA has Granted Breakthrough - GlobeNewswire

Acrivon Therapeutics Announces FDA has Granted Breakthrough GlobeNewswire

Published: Feb. 5, 2025, 1:19 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!